GHK-Cu 20mg — Vial Spec, Reconstitution Math & COA
The 20mg vial specification of GHK-Cu provides primary research facilities with a high-capacity unit ideal for multi-plate cell culture assays and extended preclinical tissue remodeling studies. This technical document outlines the chemical parameters, reconstitution mathematics, analytical validation, and laboratory handling protocols for GHK-Cu 20mg vials.
Quick answer
The 20mg vial specification of GHK-Cu provides primary research facilities with a high-capacity unit ideal for multi-plate cell culture assays and extended preclinical tissue remodeling studies. This technical document outlines the chemical parameters, reconstitution mathematics, analytical validation, and laboratory handling protocols for GHK-Cu 20mg vials.
Key takeaways
- Glycyl-L-histidyl-L-lysine copper complex ([GHK-Cu](/research-peptides/ghk-cu)) is a naturally occurring tripeptide-copper complex widely investigated in extracellular matrix (ECM) biology, regenerative tissue models, and cellular signaling pathways.
- [GHK-Cu](/research-peptides/ghk-cu) operates primarily as a signal peptide and copper transporter.
- Reconstitution of a 20mg lyophilized [GHK-Cu](/research-peptides/ghk-cu) vial requires precise diluent volumetric calculations to ensure accurate concentration delivery across cell culture wells or microfluidic assays.
- Lyophilized [GHK-Cu](/research-peptides/ghk-cu) exhibits high chemical stability when stored at -20°C to -80°C in a desiccated, light-protected environment.
Overview of GHK-Cu 20mg Mass Specification and Lab Availability
Glycyl-L-histidyl-L-lysine copper complex (GHK-Cu) is a naturally occurring tripeptide-copper complex widely investigated in extracellular matrix (ECM) biology, regenerative tissue models, and cellular signaling pathways. A 20mg vial mass specification provides a concentrated, high-yield substrate designed to support medium- to large-scale laboratory workflows, reducing batch-to-batch variation across repeated assay runs.
When planning laboratory inventory, principal investigators must evaluate whether a 20mg format aligns with their current experimental throughput. For researchers seeking smaller baseline units or alternative mass configurations, PX1 Research provides fully characterized options within our main GHK-Cu product catalog, as well as our broader index of research compounds available on the all peptides directory. If a specific single-vial mass spec is temporarily out of stock or assigned to custom synthesis queues, equivalent molar quantities can be easily assembled from standard unit offerings.
Molecular Profile and Mechanism of Action in Tissue Remodeling
GHK-Cu operates primarily as a signal peptide and copper transporter. The tripeptide sequence possesses a high affinity for divalent copper ions (Cu2+), forming a stable chelate that facilitates cellular copper uptake. In extracellular environments, copper is a critical cofactor for enzymes such as lysyl oxidase (LOX), which catalyzes the cross-linking of collagen and elastin fibers necessary for structural tissue integrity.
Preclinical studies suggest that GHK-Cu modulates gene expression involved in tissue repair and extracellular matrix dynamics. In vitro data indicate that GHK-Cu stimulates mRNA expression and protein synthesis for collagen Type I, collagen Type III, and elastin in human dermal fibroblast cultures. Furthermore, animal models evaluating dermal wound closure demonstrate enhanced cell migration, accelerated re-epithelialization, and reduced fibrotic scarring following administration of GHK-Cu in controlled gel or liquid media.
Reconstitution Math and Concentration Tables for 20mg Vials
Reconstitution of a 20mg lyophilized GHK-Cu vial requires precise diluent volumetric calculations to ensure accurate concentration delivery across cell culture wells or microfluidic assays. Depending on the target working concentration, common diluent volumes include 1.0 mL, 2.0 mL, or 3.0 mL of sterile Bacteriostatic Water or Phosphate-Buffered Saline (PBS, pH 7.4).
To calculate working concentrations (C = Mass / Volume): Reconstituting 20 mg in 1.0 mL yields a final stock concentration of 20.0 mg/mL (20.0 µg/µL). Adding 2.0 mL diluent yields 10.0 mg/mL (10.0 µg/µL). Reconstituting with 3.0 mL diluent yields approximately 6.67 mg/mL (6.67 µg/µL). For rapid verification of custom volumetric working stocks or serial dilutions, researchers are encouraged to utilize our interactive laboratory reconstitution calculator.
Aliquot Planning and Long-Term Stability Protocols
Lyophilized GHK-Cu exhibits high chemical stability when stored at -20°C to -80°C in a desiccated, light-protected environment. However, once reconstituted into aqueous media, the copper-peptide complex becomes susceptible to hydrolytic degradation and potential enzymatic cleavage if sterile protocols are compromised.
To preserve peptide integrity and avoid repeated freeze-thaw cycles—which degrade tertiary peptide structures and induce copper dissociation—laboratories should aliquot reconstituted stock solutions immediately into single-use microcentrifuge tubes. Reconstituted aliquots stored at 2°C to 8°C should be utilized within 14 days, whereas aliquots frozen at -80°C retain analytical stability for up to 6 months. Exposure to strong UV light and redox-active metals should be strictly minimized.
Quality Assurance: Lot-Matched HPLC, Mass Spectrometry, and COA Verification
Assay reproducibility depends entirely on chemical purity and exact fill mass. PX1 Research subjects every production lot of GHK-Cu to rigorous quality control protocols executed in ISO 17025 accredited analytical facilities located in the USA. Every vial is verified via High-Performance Liquid Chromatography (HPLC) to guarantee a chemical purity profile exceeding 99.0%.
Additionally, Electrospray Ionization Mass Spectrometry (ESI-MS) confirms exact molecular mass identity, ensuring the precise chelation of copper to the tripeptide backbone. Standardized Chromogenic Limulus Amebocyte Lysate (LAL) testing is conducted on every fill size to ensure endotoxin levels remain below strictly controlled research thresholds (<0.01 EU/mg). Investigators can review or download batch-specific analytical certificates directly through our dedicated COA lookup portal.
Comparative Analysis: GHK-Cu vs. Related Research Peptides
In extracellular matrix remodeling and tissue regeneration research, GHK-Cu is often evaluated alongside other cellular repair signals. While GHK-Cu functions primarily via copper transport and lysyl oxidase activation, compounds such as BPC-157 operate through angiogenic upregulation (VEGFR2 pathways) and focal adhesion kinase stimulation. Similarly, TB-500 acts as an actin-sequestering peptide (Thymosin Beta-4 domain) promoting cellular motility and cytoskeletal reorganization.
When anti-inflammatory signaling and dermal matrix repair are studied in tandem, researchers frequently contrast GHK-Cu with tripeptide variants like KPV, which targets alpha-MSH receptors to suppress NF-kB activity. Understanding these distinct pathways allows principal investigators to design targeted multi-peptide assay panels tailored to specific wound healing or fibrotic control models.
In Vitro and Animal Model Assay Design Considerations
When designing in vitro experiments using 20mg GHK-Cu stocks, cell culture media supplementation must account for baseline copper levels to prevent cellular toxicity. Dermal fibroblast proliferation and collagen deposition assays typically evaluate GHK-Cu concentrations ranging from 1 nM to 10 µM. Preclinical studies suggest that higher micromolar concentrations promote matrix metalloproteinase (MMP) expression to clear damaged ECM, whereas lower nanomolar concentrations selectively promote new collagen synthesis.
In rodent wound-closure models, GHK-Cu is typically formulated into topical hydrogels or administered via micro-incisional site injections. Investigators evaluating fibrotic scarring measure markers such as Transforming Growth Factor-beta 1 (TGF-β1) alongside Hydroxyproline content to quantify total collagen density and structural organization over 14-to-28-day study windows.
Mass Selection Strategy: When to Choose 20mg vs. Alternate Vial Specs
Selecting the appropriate vial mass spec depends on experimental duration, screening scale, and stability requirements. A 20mg GHK-Cu vial is optimal for high-throughput screening, multi-well kinetic assays, or extensive animal cohort studies requiring consistent dosing from a single analytical batch over several weeks.
Conversely, small-scale pilot studies, exploratory in vitro titrations, or short-term assay runs may benefit from smaller mass options (e.g., 5mg or 10mg) to eliminate redundant freeze-thaw cycles and minimize stock degradation. Evaluating total volumetric requirements prior to procurement ensures optimal resource allocation and experimental consistency.
Institutional Procurement, Supply Chain Integrity, and Bulk Ordering
PX1 Research operates as a primary domestic source for USA-manufactured research peptides. Operating out of centralized fulfillment hubs in California and Arizona, we provide standard same-day shipping for orders placed before daily cutoff times, ensuring strict temperature-controlled logistics and rapid transit to institutional laboratories nationwide.
For academic departments, contract research organizations (CROs), and industrial laboratories requiring bulk volumes or customized mass fills, our institutional team offers tailored batch production and volume pricing. Visit our dedicated wholesale laboratory accounts page to request institutional quotes, custom fill specifications, or lot-reserved inventory agreements.
Frequently Asked Questions
What is the physical appearance of reconstituted GHK-Cu 20mg?
Upon reconstitution with sterile water or aqueous buffer, pure GHK-Cu forms a characteristic clear, distinct blue solution. The intense blue coloration is caused by the chelated divalent copper ion (Cu2+) bound to the tripeptide sequence.
What diluent is recommended for reconstituting a 20mg GHK-Cu vial?
For standard laboratory assays, sterile Bacteriostatic Water or sterile Phosphate-Buffered Saline (PBS, pH 7.4) is recommended. If the solution is intended for cell culture workflows, sterile tissue-grade PBS or molecular biology grade water without preservatives should be used.
How does PX1 Research verify the purity of GHK-Cu 20mg vials?
Every lot undergoes independent HPLC testing to confirm purity (>99.0%), ESI-MS to confirm molecular identity, and LAL assays to confirm endotoxin levels (<0.01 EU/mg). Batch-specific COAs are published online.
Can reconstituted GHK-Cu 20mg stock solutions be frozen?
Yes. Reconstituted stock solutions can be aliquoted into single-use polypropylene tubes and frozen at -80°C for up to 6 months. Avoid repeated freeze-thaw cycles, which can cause peptide cleavage and copper ion dissociation.
Why is GHK-Cu studied in fibrotic scarring research?
Preclinical studies indicate that GHK-Cu modulates both collagen synthesis and matrix metalloproteinases (MMPs), balancing ECM assembly with controlled breakdown to prevent excessive, disorganized collagen accumulation in wound models.
What should I do if PX1 Research does not have the 20mg vial size listed currently?
If the 20mg unit is out of stock, equivalent total mass can be obtained by ordering multiple smaller unit sizes (such as 10mg vials) from our catalog, maintaining the exact same analytical purity and COA standards.
Is GHK-Cu 20mg suitable for veterinary or clinical administration?
No. All products sold by PX1 Research are strictly intended for laboratory in vitro and preclinical research use only. They are not cleared for clinical, therapeutic, human, or veterinary application.
Related pages
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.